Could a tiny dose of an alcohol addiction drug ease vasculitis symptoms?
NCT ID NCT03482479
First seen Jan 23, 2026 · Last updated Jun 01, 2026 · Updated 24 times
Summary
This study tested whether a low dose of naltrexone, a drug normally used for alcohol dependence, can improve physical health and quality of life in people with vasculitis (a group of rare blood vessel diseases). Sixty adults with different types of vasculitis took either the low dose drug or a placebo. The goal was to see if the drug could reduce symptoms like pain and fatigue better than a placebo.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GIANT CELL ARTERITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
-
Cleveland Clinic
Cleveland, Ohio, 44195, United States
-
Mayo Clinic
Rochester, Minnesota, 55905, United States
-
St. Joseph's Healthcare
Hamilton, Ontario, Canada
-
University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
-
University of Pittsburgh
Pittsburgh, Pennsylvania, 15260, United States
-
University of Utah
Salt Lake City, Utah, 84112, United States
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.